Patent Awarded for Saliva-Based Test to Diagnose & Predict Concussions
The USPTO awarded Quadrant Biosciences with U.S. Patent No.11,453,914 for the analysis and prediction of mild traumatic brain injury.
Category: Cerebrovascular
Cerebrovascular
Latest
Cerebrovascular
LatestFDA Clears High-Sensitivity Troponin-I Blood Test from Abbott
The newly cleared diagnostic could help identify heart attacks several hours sooner than standard troponin tests—and help improve diagnoses in women.
Cerebrovascular
Latest
New Microtip Partnership Assays for Diabetes, Cardiac, and Renal Testing
Glycated serum protein, lipoprotein (a), and cystatin c Microtip Partnership assays are now available for use on the Vitros 4600 clinical chemistry system and the Vitros 5600 integrated chemistry and immunoassay system.
October 2017 Product Spotlight: Lab Automation
This month’s issue features a molecular diagnostics system from XimedicaDx, a clinical chemistry analyzer from Randox Laboratories, and a sorting instrument from Yaskawa Motoman.
Read More
Hamilton Adds to Precision Syringe Drive Portfolio
The device blends enhanced slow-flow rates with precision dispensing for increased application flexibility across a wide volume range.
Read MorePharmacogenomics in Clinical Practice
Clinicians are using pharmacogenomic testing to identify gene-drug interactions to guide precise patient therapies.
Read MoreInside Track: A Fresh Look at Colorectal Cancer
David A. Ahlquist, MD, coinventor of the Cologuard stool-based DNA screening test for colorectal cancer, discusses updated USPSTF guidelines that seek to increase screening rates.
Read MoreKey Findings from the WHO Report on Diabetes
The number of people living with diabetes and its prevalence are growing in all regions of the world.
Read MoreNovel Anticoagulant Candidates Developed for Cardiovascular Market
Candidates have demonstrated comparable preclinical efficacy to existing anticoagulants but with substantially lower bleeding liability.
Read More
Cardiovascular Disease Diagnostics and Testing
Current and emerging cardiac markers are signaling improved testing for better patient outcomes.
Read More
The Value of Diagnostics
The conclusion to our three-part series exploring the value of diagnostics.
Read More
Study Signifies Progress for Cardiovascular Disease Treatment and Personalized Medicine
The DiscoveryMap platform from Myriad RBM has identified combinations of 15 protein biomarkers associated with cardiovascular events in patients with diabetes.
Read More
Flow Cytometry in the Clinical Lab
Lab professionals can expect that flow cytometry will continue to evolve in new directions with even greater utility for clinical testing.
Read More
Inside Track: Help Wanted
The biennial ASCP vacancy survey has captured a profession in transition.
Read More
Sepsis Diagnosis: The Path Forward
Over the past decade, the number of hospital admissions for sepsis following healthcare-associated infections and community-acquired infections has increased up to three-fold.
Read More
NIH Grants Seek Best Ways to Combine Genomic Information and EHRs
Researchers seek to better understand the genomic basis of disease, and provide tailored care to patients.
Read MoreCommon Heart Attack Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Read More
Two Biomarkers Predict Increased Risk for “Silent” Strokes
The concept of prevention is expanding, notes principal investigator Christie Ballantyne, MD, director of the Center for Cardiovascular Disease Prevention at The Methodist Hospital.
Read More